Upcoming WST earnings date and every past earnings report, with free AI analysis of each 10-K and 10-Q straight from SEC EDGAR filings.
October 21, 2026before market open
West Pharmaceutical Services is scheduled to report earnings on this date according to earnings-calendar data from Finnhub and Financial Modeling Prep. Dates can change until the company officially confirms them.
West Pharmaceutical Services (WST) delivered strong Q2 FY2026 results with revenue up 13.8% YoY to $872.3M and net income up 16.8% to $154.0M, driven by robust…
WST delivered a strong Q1 FY2026 with revenue surging 21.0% YoY to $844.9M and operating income jumping 65.5% to $177.1M, driven by significant margin…
WST delivered solid FY2025 results with revenue growing 6.3% to $3.07B and gross margin expanding 140 bps to 35.9%, though net income was nearly flat at…
West Pharmaceutical Services (WST) is scheduled to report earnings on October 21, 2026, before market open, according to Finnhub's earnings calendar. Dates can change until the company officially confirms them.
West Pharmaceutical Services's most recent earnings report was its Q2 FY2026 10-Q, filed with the SEC on July 23, 2026.
EarningsLens publishes free AI analysis of every WST 10-K and 10-Q filing. The latest covers Q2 FY2026 — open it from the report history on this page.
Like all U.S.-listed public companies, West Pharmaceutical Services reports four times a year: three quarterly 10-Q filings and one annual 10-K filing with the SEC.